Xortx Therapeutics INC F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
XORTX Therapeutics Inc. is offering up to 4,761,904 common shares, pre-funded warrants, and common warrants to raise approximately $3.8 million for R&D and working capital.
NASDAQ
XORTX Therapeutics has filed a registration statement for the resale of up to 810,810 common shares issuable upon the exercise of warrants held by a selling shareholder.